Remarkably, the overexpression of IF1 in hepatocarcinomas48, gastric49, lung50 and bladder51 carcinomas and gliomas52 identifies patients with worst prognosis because IF1 favors proliferation and metastatic disease. Here, ATP5IF1 is linked to metastatic neoplasm.